TOP GUIDELINES OF IBREXAFUNGERP

quinupristin/dalfopristin will raise the level or outcome of avanafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. CYP3A4 inhibitors may reduce avanafil clearance increasing systemic exposure to avanafil; elevated levels may bring about improved related adverse events; the most advisable dose of STENDRA is 50 mg, n